Syngene eyes growth tailwinds from global trial wins, biotech funding recovery: CEO
Published on: Nov. 9, 2025, 5:29 p.m. | Source: The Hindu Business Line
Syngene's CEO highlights growth potential from global trials and biotech funding recovery, despite current profitability challenges.
